SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Catalent completes expansion of US complex tablet site

16-Apr-2015 - Catalent has doubled production capacity and added extra analytical lab space at its facility in Winchester, Kentucky, US.

WuXi offers more details on the complexity of CRO, CMO competition

15-Apr-2015 - Competition in the notoriously tight-lipped CRO (contract research organization) and CMO (contract manufacturing organization) industries is getting fiercer as outsourcing picks up, though that hasn’t stopped one Chinese company from...

Recipharm invests in metal-linked API delivery tech in Synthonics deal

15-Apr-2015 - Recipharm has invested $2m (EUR1.8m) in metal co-ordinated chemistry (MCC) specialist Synthonics in a deal that will also see it help develop the US firm’s range of targeted drug products....

Dispatches from BPI 2015

Pfizer's vetting process sorts the strategic CMOs from the casual flings

15-Apr-2015 - Looking for a full-on partnership with Pfizer or a no-strings-attached manufacturing deal? Either way prepare for a tough screening process and don't be located too far from an airport.

Almac to relocate protein business to up capacity and add new services

13-Apr-2015 - Almac will transfer its custom peptide manufacturing business to a site at the Edinburgh Technopole business park in Scotland’s capital in a £3.5m move designed to expand capacity.

What links gin, 1960s pop balladeer Donovan and Molecular Profiles?

13-Apr-2015 - Molecular Profiles has changed its name to Juniper Pharma Services in a move designed to facilitate further expansion in the US.

News in brief

Aptuit to expand API capacity in UK, Italy due to increasing demand

06-Apr-2015 - Connecticut-based CMO Aptuit opened a 1600L/1000L reactor stream at its API facility in Oxford, UK, and increased throughput at its 400L reactors at its site in Verona, Italy.

News in brief

AMRI to lay off 62 in closing of UK manufacturing facility

06-Apr-2015 - AMRI has confirmed it will close its Holywell, UK facility and let go 62 employees from the site following a consultation with employee representatives. 

WuXi sells small share of CMO subsidiary for $28m

06-Apr-2015 - Chinese service provider WuXi PharmaTech has sold a 5.55% stake in its wholly owned CMO (contract manufacturing organization) subsidiary SynTheAll Pharmaceutical (STA) to members of STA’s and WuXi’s management for $28m....

Alkermes downgraded on concerns about ability to compete in crowded markets

03-Apr-2015 - Alkermes has been downgraded by analysts who say the success of its decision to focus on own-brand products and sell its legacy CMO site hinges on its ability to win...

US military strikes deal to secure adenovirus shots from Teva

03-Apr-2015 - Supply of the Adenovirus Type 4 and Type 7 Vaccine to all US military personnel has been secured through a five-year contract with Teva worth $170m (€156m).

Onyx Scientific expands API facility on Phase I/II demand

01-Apr-2015 - A rise in demand for small scale APIs has driven Onyx Scientific to expand its GMP operations in North-East England.

‘Game changer’: latest GDP rules spell full traceability for APIs

26-Mar-2015 - Makers and distributors of APIs (active pharmaceutical ingredients) will have to track their products throughout the supply chain and meet rules on cold chain transport and outsourcing under revised guidance...

News in brief

Adroit collaboration: Recipharm teams with solid state formulation firm

26-Mar-2015 - Swedish CMO Recipharm has teamed up with formulations and solid state chemistry firm Adroit Science in a strategic collaboration.

Growth with aid of Grey: Elderly folks to drive excipients sector, study

24-Mar-2015 - Demand for pensioner friendly pills will be an important growth driver for the drug excipients sector according to new analysis.

Rentschler brings single-use system online

23-Mar-2015 - Rentschler Biotechnologie has increased single-use bioreactor capacity at its manufacturing site in Laupheim, Germany and is moving forward with plans to invest €25m ($27m) in a new stainless steel system...

News in brief

Nanobiotix appoints CordenPharma as CMO for potential nanoparticle-based cancer treatment

19-Mar-2015 - The late clinical-stage nanomedicine company Nanobiotix has selected CordenPharma as its contract manufacturing partner. 

ImmunoCellular taps PharmaCell to manufacture dendritic cell-based vaccine for trial

19-Mar-2015 - European CMO PharmaCell B.V. has finalized an agreement with ImmunoCellular Therapeutics to support its pivotal phase III clinical trial in Europe with ICT-107, a dendritic cell-based vaccine in development for...

Exclusive interview

Rise in outsourcing to lead to further CMO consolidation, DPx CEO says

18-Mar-2015 - The CMO (contract manufacturing organization) industry is ripe for consolidation as the rise in outsourcing continues and clients look to simplify their supply chains, DPx CEO James Mullen told Outsourcing-Pharma.com...

Update

WuXi to more than double US cell therapy manufacturing ops with new site

12-Mar-2015 - China-based CDMO WuXi PharmaTech unveiled Thursday that it will soon begin construction on its third cell therapy manufacturing facility -- a 145,000-square-foot cGMP facility in Philadelphia. 

WHO: Smart needles key to preventing new hep B infections

12-Mar-2015 - New hepatitis B treatment guidelines advocate use of Gilead and BMS drugs and underline WHO concerns that needle reuse spreads the virus.

AMRI sets sights on acquiring Indian API manufacturer, CEO says

11-Mar-2015 - Following its three acquisitions over the last year, AMRI is now looking to extend its footprint into India further with the acquisition of a FDA-approved API site, William Marth, president...

Penn invests in pill tech citing industry demand

11-Mar-2015 - Penn Pharma has added new tablet making technology at its facility in Tredegar, Wales citing drug industry demand for dry granulation manufacturing capacity.

Orgenesis buys cell therapy CMO to cut manufacturing costs and diversify revenue stream

11-Mar-2015 - Orgenesis has bought Masthercell SA to take control of production of its Type 1 diabetes cell therapy candidate ahead of clinical trials.

Patheon focuses on solubility with acquisition of Oregon-based CDMO

09-Mar-2015 - For the second time in just over a week, CDMO Patheon has made an acquisition, this time for Agere Pharmaceuticals, a privately held CDMO based in Bend, Oregon, that specializes...

Key Industry Events